A key gene modulating oxytocin efficacy in autism: genome-wide discovery and verification in randomized controlled trials datasets.
Kuwabara H, Kojima M, Benner S, Otowa T, Watanabe T, Kuroda M, Owada K, Yassin W, Hamada J, Kano Y, Uno Y, Kushima I, Mori D, Arioka Y, Munesue T, Kasai K, Higashida H, Abe O, Takao H, Wakuda T, Kameno Y, Inoue J, Harada T, Yamauchi A, Ogawa N, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Takahashi N, Nakashima M, Saitsu H, Kondo K, Ikeda M, Iwata N, Shimada M, Sasaki T, Takei N, Ozaki N, Kosaka H, Okada T, Yamasue H.
Kuwabara H, et al.
Mol Psychiatry. 2026 Aug;31(8):4475-4482. doi: 10.1038/s41380-026-03562-y. Epub 2026 Mar 28.
Mol Psychiatry. 2026.
PMID: 41904269
Clinical Trial.
Previous studies suggest that oxytocin has therapeutic potential for modulating core symptoms of autism spectrum disorder (ASD), although findings have been inconsistent. The unknown mechanisms underlying oxytocin's effects and the substantial individual variability …
Previous studies suggest that oxytocin has therapeutic potential for modulating core symptoms of autism spectrum disorder (ASD …